A holistic approach to targeting disease with polymeric nanoparticles
Open accessThe DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.
Abstract
The primary goal of nanomedicine is to improve clinical outcomes. To this end, targeted nanoparticles are engineered to reduce non-productive distribution while improving diagnostic and therapeutic efficacy. Paradoxically, as this field has matured, the notion of targeting has been minimized to the concept of increasing the affinity of a nanoparticle for its target. This Opinion article outlines a holistic view of nanoparticle targeting, in which the route of administration, molecular characteristics and temporal control of the nanoparticles are potential design variables that must be considered simultaneously. This comprehensive vision for nanoparticle targeting will facilitate the integration of nanomedicines into clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Encapsulation of hepcidin into biocompatible nanocarriers suitable for controlled release of therapeutics (Cheng et al., 2015) could theoretically address this issue.”
From Pharmacological Targeting of the Hepcidin/Ferroportin Axis (2016) · cites this paper as Cheng et al., 2015
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biodegradable polymeric nanoparticles as drug delivery devices
Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R., & Rudzinski, W. E. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00339-4 · Cited by 3,549
Biomolecular coronas provide the biological identity of nanosized materials
Monopoli, M. P., Åberg, C., Salvati, A., & Dawson, K. A. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.207 · Cited by 3,017
Bertrand, N., Wu, J., Xu, X., Kamaly, N., & Farokhzad, O. C. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.009 · Cited by 2,824
Effect of Surface Properties on Nanoparticle–Cell Interactions
Verma, A., & Stellacci, F. (2010) · Small · doi:10.1002/smll.200901158 · Cited by 2,619
He, C., Hu, Y., Yin, L., Tang, C., & Yin, C. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.065 · Cited by 2,607
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Davis, M. E., Zuckerman, J. E., Choi, C. H. J., Seligson, D., Tolcher, A., Alabi, C. A., Yen, Y., Heidel, J. D., & Ribas, A. (2010) · Nature · doi:10.1038/nature08956 · Cited by 2,505
Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology
Tenzer, S., Docter, D., Kuharev, J., Musyanovych, A., Fetz, V., Hecht, R., Schlenk, F., Fischer, D., Kiouptsi, K., Reinhardt, C., et al. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2013.181 · Cited by 2,283
Sahay, G., Alakhova, D. Y., & Kabanov, A. V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.01.036 · Cited by 2,181
Salvati, A., Pitek, A. S., Monopoli, M. P., Prapainop, K., Bombelli, F. B., Hristov, D. R., Kelly, P. M., Åberg, C., Mahon, E., & Dawson, K. A. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2012.237 · Cited by 1,912
Exploiting the enhanced permeability and retention effect for tumor targeting
Iyer, A. K., Khaled, G., Fang, J., & Maeda, H. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.07.005 · Cited by 1,846
Research works printed but not linked: 5
- Bertrand N Leroux JC The journey of a drug-carrier in the body: an anatomo-physiological perspective Journal of Controlled Release: Official Journal of the Controlled Release Society 161 152 163 2012 22001607
- Davis ME Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles Nature 464 1067 U140 2010 20305636 PMC2855406
- Wang YC Sustained intraspinal delivery of neurotrophic factor encapsulated in biodegradable nanoparticles following contusive spinal cord injury Biomaterials 29 4546 4553 2008 18774604
- Kaur IP Kakkar S Nanotherapy for posterior eye diseases Journal of Controlled Release: Official Journal of the Controlled Release Society 2014 24862316
- Li H A PEDF N-terminal peptide protects the retina from ischemic injury when delivered in PLGA nanospheres Experimental Eye Research 83 824 833 2006 16822505
Cited by
Items 401–492 of 492
Naeem, Z., Rana, T., & Javaid, S. (2023) · Currents in pharmaceutical research · doi:10.32350/cpr.11.03 · Cited by 4
Engineering cyclized biomolecules for advanced diagnostic and therapeutic applications
Lee, Y., Oh, B., Kang, S., Kim, S., & Kim, Y. (2025) · Biotechnology Advances · doi:10.1016/j.biotechadv.2025.108694 · Cited by 3
Recent advances in “bioartificial polymeric materials” based nanovectors
Conte, R., Luca, I. D., Valentino, A., Salle, A. D., Calarco, A., Riccitiello, F., & Peluso, G. (2017) · Physical Sciences Reviews · doi:10.1515/psr-2016-0131 · Cited by 3
Cancer Nanotherapeutics Administered by Non-conventional Routes
Roche, K. C., Medik, Y. B., Rodgers, Z., Warner, S., & Wang, A. Z. (2018) · Bioanalysis · doi:10.1007/978-3-030-01775-0_11 · Cited by 3
Advancement of Nanocarriers-based Therapeutics for Effective Management of Colorectal Cancer
Ashique, S., Upadhyay, A., Kumar, S., Mishra, N., Garg, A., Rai, S., Altamimi, M. A., Hussain, A., & Rihan, M. (2023) · Current Indian Science · doi:10.2174/2210299x01666230224095321 · Cited by 3
Nanotherapeutics for solid organ transplantation: new kid on the block
Xu, G., Duan, Z., Luo, K., & Yang, J. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104624 · Cited by 3
"Nano, Micro, and Macro Materials in Scaffolds for Biomedical Applications: A Review"
Sathish, T. (2022) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2022.46.007355 · Cited by 3
Gholami, R., & Naghib, S. M. (2025) · Biological and medical physics, biomedical engineering · doi:10.1007/978-981-96-0041-0_4 · Cited by 4
Medical Applications of Nanomaterials
Vedda, A., & Villa, I. (2017) · NATO science for peace and security series. B, Physics and biophysics · doi:10.1007/978-94-024-0850-8_18 · Cited by 3
Klepac, D., Tavares, M. R., Vragović, M., Ogrizović, R., Valić, S., Kereïche, S., Filippov, S. K., Etrych, T., Čakara, D., & Chytil, P. (2025) · European Polymer Journal · doi:10.1016/j.eurpolymj.2025.113727 · Cited by 2
Role of Carbohydrate-Based Nanomaterials in Therapeutic and Diagnostic Applications
Vijayalakshmi, P., Mohan, N., Srinivas, T., Dharshini, B. P., Vaddadi, U. R., & Alle, M. (2025) · Smart nanomaterials technology · doi:10.1007/978-981-96-2171-2_7 · Cited by 2
Surface-Modified Nanodrug Carriers for Brain Cancer Treatment
Wadajkar, A. S., Connolly, N. P., Carney, C. P., Kanvinde, P. P., Winkles, J. A., Woodworth, G. F., & Kim, A. J. (2020) · Neuromethods · doi:10.1007/978-1-0716-1052-7_5 · Cited by 2
Bernardi, N. S., Jesus, S., & Borges, O. (2023) · Journal of biomimetics, biomaterials and biomedical engineering · doi:10.4028/p-ns8294 · Cited by 2
Potential Neuroprotective Strategies using Smart Drug Delivery Systems for Alzheimer’s Disease
Khan, J., Yadav, S., & Alam, A. (2023) · Infectious Disorders - Drug Targets · doi:10.2174/0118715265254985231012065058 · Cited by 3
Small interfering RNA: potential in real-world clinical practice
Motrinchuk, A. S., & Kasimova, A. R. (2024) · Real-World Data & Evidence · doi:10.37489/2782-3784-myrwd-46 · Cited by 3
Huang, L., Wang, J., Chen, S., Xv, X., Li, Y., Li, G., & Tang, Z. (2024) · Brain Hemorrhages · doi:10.1016/j.hest.2024.04.004 · Cited by 2
The Emergence of Nanopharmacy: From Biology to Nanotechnology and Drug Molecules to Nanodrugs
Hadjidemetriou, M., Al-Ahmady, Z. S., Mazza, M., & Kostarelos, K. (2016) · Wiley eBooks · doi:10.1002/9783527800681.ch3 · Cited by 3
Nanoparticles for DNA delivery
Mahato, M., Sharma, A. K., & Kumar, P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-08-100557-6.00004-3 · Cited by 3
Design of targeting peptides for nanodrugs for treatment of infectious diseases and cancer
Glišić, S., & Veljković, V. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813689-8.00009-4 · Cited by 4
Clinical Applications of Tumor-targeted Systems
Zhang, X. (2020) · Springer eBooks · doi:10.1007/978-981-15-5159-8_13 · Cited by 2
Current systems biology approaches in hazard assessment of nanoparticlesPreprint
Ehrhart, F., Evelo, C. T., & Willighagen, E. (2015) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/028811 · Cited by 2
Enhancing the bioavailability of BCS Class IV drugs using polymeric nanoparticles
Soundararajan, R. (2016) · UCL Discovery (University College London) · Cited by 4
Advanced drug delivery systems for enhancing the efficacy of RNA-based therapeutics
Alhabib, N. A., Almaniea, M. A., Alehaidib, S. M., Almansour, M. A., Aldosary, M. S., Almegbel, M. T., Alsubaie, S. A., & Alzahrani, A. M. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns10.15029 · Cited by 1
Spiewok, S., Jansen, F., Han, J., Lamla, M., von Delius, M., Trautwein, C., Laporte, L. D., & Kuehne, A. J. C. (2025) · Advanced NanoBiomed Research · doi:10.1002/anbr.202400187 · Cited by 1
4.30 Nanomaterials for Drug Delivery to the Brain
Gaudin, A., Seo, Y.-E., Song, E., Quijano, E., King, A. R., & Saltzman, W. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803581-8.09288-2 · Cited by 1
Self-citationSalman, M., Babar, S., & Mariam, M. N. J. G. (2023) · Advances in digital crime, forensics, and cyber terrorism book series · doi:10.4018/978-1-6684-8325-1.ch006 · Cited by 1
Strategies for Targeted Delivery via Structurally Variant Polymeric Nanocarriers
Chakraborty, G., Meher, M., Dash, S., Rout, R. N., Pradhan, S., & Sahoo, D. (2023) · ChemistrySelect · doi:10.1002/slct.202301626 · Cited by 1
Advanced Mesoporous Silica Nanoparticles: Synthesis, Characteristics and Applications
Mohamed, A. A., Kamil, M. M., Rahi, F. A., & Kbah, N. Z. (2023) · Maaen Journal for Medical Sciences · doi:10.55810/2789-9136.1019 · Cited by 1
Advancement of nanoparticles in tissue engineering
Chowdhury, S., Chakraborty, P., Kar, K., Mazumder, K., & Mondal, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95134-0.00002-x · Cited by 2
Nanomedicines to Improve Oral Delivery of Antiretroviral Drugs
Katari, O., & Jain, S. (2023) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-031-39020-3_9 · Cited by 1
Feng, L., Chen, Z., Dong, W., Xie, A., Zang, X., & Li, J. (2023) · New Journal of Chemistry · doi:10.1039/d3nj04530g · Cited by 1
Nanoparticles Solutions for Allergic Airway Disorders: Current Trends and Future Prospects
Mondal, S., Maan, S., Rani, I., Jatrana, A., Ankita, A., Kumar, A., Verma, S., Prasher, P., & Mudila, H. (2024) · Springer eBooks · doi:10.1007/978-981-97-1953-2_10 · Cited by 1
Advancements in macromolecular complexity and their implications for drug delivery systems
Hamzy, I. A., Alqhoson, A. I., Aljarbou, A. M., & Alhajri, M. A. (2018) · International Journal of Health Sciences · doi:10.53730/ijhs.v2ns1.15093 · Cited by 1
PULMONARY DELIVERY OF RESVERATROL-LOADED NANOCOMPOSITE MICROPARTICLES TO TREAT LUNG CANCER
Muller, A. G. (2020) · Liverpool John Moores University · doi:10.24377/ljmu.t.00012213 · Cited by 1
Novel Paclitaxel Nanoparticles for Enhanced Therapeutic Effects in Breast Cancer
Chowdhury, P. (2020) · doi:10.21007/etd.cghs.2020.0500 · Cited by 7
Formulation and Characterization of Lipogels as a Tunable Delivery Scaffold
Homyak, C. (2018) · ScholarWorks@UMassAmherst (University of Massachusetts Amherst) · doi:10.7275/11240575.0
Ballesteros, C. A. S. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.76.2017.tde-14092017-143257
Chan, C. (2017) · eScholarship (California Digital Library)
Miranda, B. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.75.2019.tde-14032019-095025
Biohybrid Cloaked Nanovaccines For Cancer Immunotherapy
Fontana, F. (2019) · Helda - University of Helsinki Institutional Repository
Engineering Biomaterial Properties for T Cell Immunotherapy
Hickey, J. W. (2019)
Liggitt, H. D. (2019) · Springer eBooks · doi:10.1007/978-3-662-59600-5_3
Evaluation of immunotoxicological properties of PCL and PCL/Glucan nanoparticles
Bernardi, N. S. (2019) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Zelenina, O. M., Остапив, Д. Д., Dron, І. A., Samaryk, V., Kosenko, Y. M., & Vlizlo, V. (2020) · Naukovì dopovìdì Nacìonalʹnogo unìversitetu bìoresursiv ì prirodokoristuvannâ Ukraïni · doi:10.31548/dopovidi2020.04.009
Assessing and reconditioning kidneys using normothermic machine perfusion
Georgiades, F., Hosgood, S. A., & Nicholson, M. L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819451-5.00011-1 · Cited by 1
Dupla modificação química do amido de mandioca com potencial uso como biomaterial.
da Silva, E. C. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.3.2019.tde-20032020-103610
Bioinspired Drug Delivery System for Anticancer Therapy.
Hu, Q. (2018) · NCSU Libraries Repository (North Carolina State University Libraries)
Tumor Cell Distinguishable Nanomedicine Integrating Chemotherapeutic Sensitization and Protection
Liu, S., Shen, C., Qian, C., Wang, J., Yang, Z., Wei, Y., Li, Q., Pan, C., Hu, Y., & Ye, W. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.773021
Experimental and Computational Study on the Inclusion of Betamethasone with CyclodextrinPreprint
Al-Sou'od, K., Al-Enazi, M., Ghanem, R. A., & Abuflaha, R. K. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4065399
Experimental and Computational Study on the Inclusion of Betamethasone with CyclodextrinPreprint
Al-Sou'od, K., Al-Enazi, M., Ghanem, R. A., & Abuflaha, R. K. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4100912
Nanoparticle-assisted oral delivery of small and large peptides
Arora, M., Zou, D., & Kumar, M. N. V. R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821061-1.00007-1
"Cell Membrane Nano Vesicles as Drug Carriers: Biomedical Applications"
Islam, M. (2022) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2022.42.006724
El-Baz, N. (2022) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/4008
Advancement of Nanocarriers-based Therapeutics for Effective Management of Colorectal Cancer
Ashique, S., Garg, A., Kumar, P., Mishra, N., Hussain, A., Upadhyay, A., Kumar, S., & Farid, A. (2023) · Current Indian Science · doi:10.2174/2210299x01666230529120441 · Cited by 1
Adetunji, C. O., Olaniyan, O. T., Egbuna, C., Ajayi, O. O., Dauda, W., Adetunji, J. B., Ghazanfar, S., Ogundolie, F. A., Mathew, J. T., Inobeme, A., et al. (2024) · Wiley eBooks · doi:10.1002/9781394234769.ch13
(2024) · Frontiers research topics · doi:10.3389/978-2-8325-4801-1
TOXICITY STUDY OF PEGYLATED ENROFLOXACIN IN ANIMAL ORGANISM
Влизло, В. В., Zelenina, O. M., & Kozak, М. R. (2024) · Izdevniecība “Baltija Publishing” eBooks · doi:10.30525/978-9934-26-454-2-1
Unveiling The Applications of Nanoparticles in Cancer Immunotherapy
Mehra, G., Singh, P., & Sharma, N. (2024) · Current Cancer Therapy Reviews · doi:10.2174/0115733947321690240902093508
Nanopartículas: Una prometedora alternativa para el tratamiento del cáncer de seno
Camargo-Herrera, L. V., Santos, L. P. H., & Lagos, S. M. R. (2024) · CIENCIA EN DESARROLLO · doi:10.19053/01217488.v15.n2.2024.16015
Advanced Drug Delivery Systems: From Microsponges to Nanotechnologies
Fiorucci, S., & Urbani, G. (2025) · Recent Advances in Inflammation & Allergy Drug Discovery · doi:10.2174/277227081901241223145542
Application of nanobiomaterials in tissue engineering, repair, and cell remodeling
Nandasana, M., Webster, T. J., & Ghosh, S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-21507-0.00001-5
Nanotechnology application in liver transplantation
Yao, C. G. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-823524-9.00019-8
Singh, I., Keshri, A., Ratn, A., Dhakad, M. S., Sharma, D., & Kunamneni, A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33072-8.00003-0
Στρατηγικές RNA θεραπείας σε μονογονιδιακά νοσήματα
PITTA, P. (2023) · University of Thessaly Institutional Repository (University of Thessaly) · doi:10.26253/heal.uth.39177
Jiang, W., Chen, J., Gong, C., Wang, Y., Gao, Y., & Yuan, Y. (2020) · Figshare · doi:10.6084/m9.figshare.12005052
Interakce nanomateriálů s nádorovou tkání
Kohoutová, E. (2021) · Digital library - University of Pardubice (University of Pardubice)
Therapeutic Vaccination in Lung Cancer: Past Attempts, Current Approaches and Future Promises
Samuel, P. Y., & Sun, J. (2025) · Journal of Respiratory Biology and Translational Medicine · doi:10.70322/jrbtm.2025.10010
Mohite, P., Bharti, D., & Gohri, V. (2025) · IGI Global eBooks · doi:10.4018/979-8-3373-4627-4.ch012
Chen, W., Ma, T., Zheng, X., Pan, R., Nan, T., Zheng, L., Lan, J., Xu, G., & Liu, H. (2025) · Research Square · doi:10.21203/rs.3.rs-8389931/v1
In utero gene therapy: Pioneering diagnostic and therapeutic technologies
Seth, S., Sen, M., Banerjee, S., Sau, R., & Ray, S. (2025) · Human Gene · doi:10.1016/j.humgen.2025.201527
Rességuier, J. (2017) · theses.fr (ABES) · doi:10.70675/97dd6123zf6a1z4243zba0ez476d927d5ec1 · Cited by 1
Maheshwari, N. O. (2017) · theses.fr (ABES) · doi:10.70675/bf29293fz4844z4c64zaecez61f758914d69 · Cited by 1
Nanoparticules multifonctionnelles pour un meilleur ciblage de la thérapie guidée par imagerie
Sánchez, G. J. (2017) · theses.fr (ABES) · doi:10.70675/ca081003zc678z47cfz8968zf83217ba1828 · Cited by 2
Drug delivery nanosystems for skeletal muscle treatment in myotonic dystrophy
Repellin, M. (2022) · theses.fr (ABES) · doi:10.70675/905c40e8z03bdz417fz889dzf4930211a75b
Application of squalenoylation in chronic pain alleviation
Silva, A. D. (2023) · theses.fr (ABES) · doi:10.70675/83a7bd41z85b4z4dcazaa47z92efc29ff8da
Nanosystems to Improve the Delivery of Biologicals
Raza, A., & Wu, W. (2025) · Springer handbooks · doi:10.1007/978-3-032-01636-2_7
Mani, R., Saranya, K., Panner, K., & Palvannan, T. (2026) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.70184
Engineered Cell Membrane-Coated Nanoparticles: A New Strategy for Pancreatic Cancer Therapy
Zhou, K., Zhang, Z., Wang, B., Zhao, C., Zhu, H., Liao, X., Li, Q., Fu, S., Tsai, H., & Feng, G. (2026) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.6c00148
Djazouli, R., Akhmetova, D. R., Rogova, A. S., & Brodskaia, A. V. (2026) · Medical academic journal · doi:10.17816/maj678889
Kou, H., Qi, L., Huang, D., & Yang, H. (2026) · International Journal of Polymeric Materials · doi:10.1080/00914037.2026.2702930
Organ transplantation application in green microbial nanotechnology for biomedical applications
Bogala, M. R. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-36765-6.00001-6
Polymer Surfactants at the Mesoscale: Packaging Liquid Droplets with Ultrathin Sheets and Filaments
Steppan, C. G., Marquard, H., Kroo, L., Russell, T. P., & Emrick, T. S. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.6c11589
Synthesis and extraction of nanocellulose
Owaid, M. N. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-41493-0.00029-5
Nanomaterials Used in Inhaled Pulmonary Delivery Systems
Nokhodchi, A., Kaialy, W., Bello, H., Momin, M. A. M., Ramezanian, S., & Ghafourian, T. (2026) · Royal Society of Chemistry eBooks · doi:10.1039/9781837676439-00005 · Cited by 1
Amphipathic peptoid transporters for protein and nanoparticle delivery
Shin, J., Kim, E., Jun, M., Yang, M. U., Erica, K. J. Y., Lee, J., Lee, J., & Lee, J. (2026) · RSC Advances · doi:10.1039/d6ra06745j
Vitamin B 12 ‐Functionalized Nanogels for pH‐, and Redox‐Responsive Doxorubicin Delivery
Dagdelen, S., Mestizo, P. D., Maćkiewicz, M., Kurdyn, A., Augustin, E., Karbarz, M., & Zelder, F. (2026) · ChemBioChem · doi:10.1002/cbic.70580
Avaliação das propriedades imunotoxicologicas das nanopartículas de PCL e PCL/Glucano
Bernardi, N. S. (2019) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Wang, J., Xu, S., Hosseinikhah, S. M., Zhang, W., Zhang, X., & Sacchetti, A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27219938
Development of nanoscale delivery systems for breast cancer treatment
Zhang, Y. (2015) · Figshare
Metadata
- Authors
- Cheng, C. J., Tietjen, G. T., Saucier-Sawyer, J. K., & Saltzman, W. M.
- Affiliations
- Yale University (US)
- Corresponding author
- Saltzman, W. Mark
- Venue
- Nature Reviews Drug Discovery
- Published
- 2015-01-19
- Volume
- 14
- Issue
- 4
- Pages
- 239-247
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- PMC
- PMC4451203
- OpenAlex
- W2041271505
- Cited by
- 480
- References
- 135
- Citations by year
- 2026: 13 · 2025: 37 · 2024: 31 · 2023: 41 · 2022: 42 · 2021: 37 · 2020: 42 · 2019: 40 · 2018: 46 · 2017: 63 · 2016: 60 · 2015: 27
- FWCI
- 3.94
- Type
- journal article
- Language
- en
- Update notices
- erratum (2015-04-30)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (T32HL007974)
- National Cancer Institute (R01CA149128, F32CA174247, CA149128)
- National Institute of Allergy and Infectious Diseases (R01AI112443, T32AI089704, AI106992, R56AI106922, AI112443)
- National Institute of Biomedical Imaging and Bioengineering (EB00487, R01EB000487)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- targeted drug delivery, polymeric nanoparticles, nanomedicine, nanoparticle targeting, route of administration, nanoparticle design, clinical translation
- MeSH terms
- Animals, Humans, Polymers, Drug Delivery Systems, Nanomedicine, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.